Lv1
38 积分 2024-01-02 加入
A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis
4小时前
待确认
Discovery of Novel Small Molecule Inhibitors Disrupting the PCSK9-LDLR Interaction
1天前
已完结
Development of a PCSK9-targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia
28天前
已完结
Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review
28天前
已完结
Linking vaccine adjuvant mechanisms of action to function
1个月前
已完结
Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment
6个月前
已完结
PCSK9 inhibitors: a patent review 2018-2023
7个月前
已完结
PCSK9-targeted therapies: present and future approaches
10个月前
已完结
Vaccine Ingredients: Components that Influence Vaccine Efficacy
1年前
已完结
A genetically engineered non-toxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit
1年前
已关闭
皖公网安备34019202002308
